PLOSopen access
Real-world implementation and cost impact analysis of Oncotype DX testing in early-stage breast cancer
adjuvant chemotherapy, cancer risk factors, oncology, cancer risk factors, cancer treatment, adjuvant chemotherapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 376021
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.